Elevance Health Operating Cash Flow — Historical Data
Elevance Health (ELV) operating cash flow was $4.3B in FY2025 (-26% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$4.3B
-26%
2024
$5.8B
-28%
2023
$8.1B
-4%
2022
$8.4B
+0%
2021
$8.4B
+38%
2019
$6.1B
+58%
2018
$3.8B
-9%
2017
$4.2B
+28%
2016
$3.3B
-22%
2015
$4.2B
+25%
2014
$3.4B
+10%
2013
$3.1B
+11%
2012
$2.7B
-19%
2011
$3.4B
+138%
2010
$1.4B
-53%
2009
$3.0B
+20%
2008
$2.5B
-42%
2007
$4.3B
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q2 2026
$1.9B
Q1 2026
$4.3B
Q4 2025
$84M
Q3 2025
$1.1B
Q2 2025
$2.1B
Q1 2025
$1.0B
Q4 2024
$706M
Q3 2024
$2.7B
Q2 2024
$447M
Q1 2024
$2.0B
Q4 2023
-$3.0B
Q3 2023
$2.6B
Source: ELV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.